ObvioHealth Announces Mobile Application to Transform Clinical Studies
Summary
“ClaimIt will help advance the latest treatments in healthcare, which is why we invested so confidently in ObvioHealth,” said Bruno de Pampelonne, CEO of Tikehau IM.As a medical technology company, ObvioHealth provides healthcare clients a data-rich platform for substantiating claims and demonstrating product safety and efficacy.This decentralized model means clinical trials can be executed from a participant’s smart phone, while leveraging the best-practices in study design, data management and medical writing–all in a streamlined platform.With a team of 600+ professionals and 19 offices globally, SPRIM helps its clients transform the newest opportunities and breakthroughs in science and health, into business and marketing realities.Tikehau Capital is controlled by its managers and leading institutional partners and employs 220 staff (as at March 31, 2018) in its Paris, London, Brussels, Madrid, Milan, New York, Seoul and Singapore offices.